Cart
sales@molnova.com
Seviteronel R enantiomer
CAS No. 1375603-38-5
Seviteronel R enantiomer( —— )
Catalog No. M33165 CAS No. 1375603-38-5
Seviteronel R enantiomer (VT-464 R enantiomer) is a Seviteronel isomer produced during the manufacturing process.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 172 | Get Quote |
|
| 5MG | 259 | Get Quote |
|
| 10MG | 377 | Get Quote |
|
| 25MG | 623 | Get Quote |
|
| 50MG | 886 | Get Quote |
|
| 100MG | 1152 | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameSeviteronel R enantiomer
-
NoteResearch use only, not for human use.
-
Brief DescriptionSeviteronel R enantiomer (VT-464 R enantiomer) is a Seviteronel isomer produced during the manufacturing process.
-
DescriptionSeviteronel R enantiomer (VT-464 R enantiomer) is the R enantiomer of Seviteronel (VT-464), which is a potent CYP17 lyase inhibitor(h-Lyase IC50=69 nM); Seviteronel (VT-464) R enantiomer's activity is unknown.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1375603-38-5
-
Formula Weight399.34
-
Molecular FormulaC18H17F4N3O3
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : ≥ 100 mg/mL (250.41 mM )
-
SMILESC(C(C)C)(O)(C1=CC2=C(C=C1)C=C(OC(F)F)C(OC(F)F)=C2)C3=CN=NN3
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Rafferty SW, et al. Highly-selective 4-(1,2,3-triazole)-based P450c17a 17,20-lyase inhibitors. Bioorg Med Chem Lett. 2014 Jun 1;24(11):2444-7.?
molnova catalog
related products
-
Eethyl pentadecanoat...
Eethyl pentadecanoate has potential insect repellent activity.
-
Mephenesin
Mephenesin is an NMDA receptor antagonist, is a centrally acting muscle relaxant.
-
BI-0474
BI-0474 is a potent KRASG12C inhibitor that inhibits GDP-KRAS::SOS1 protein-protein interactions with an IC50 value of 7.0 nM.BI-0474 exhibits significant antiproliferative activity against NCI-H358 cells harboring the G12C mutation, and shows significant anti-tumor activity in a non-small cell lung cancer xenograft model.
